KeyPlants Signs Agreement for Modular Vaccine Manufacturing Facility in Saudi Arabia
We are proud to announce that a great achievement has been reached under the distinguished patronage of Her Excellency Petra Menander, Ambassador of the Kingdom of Sweden to the Kingdom of Saudi Arabia, a comprehensive agreement for a modular vaccine manufacturing facility was signed between Vaccine Industrial Company and KeyPlants.
The project will be carried out in phases, including packaging, aseptic fill finish, and bulk vaccine manufacturing. This facility, located in Saudi Arabia, will be the largest human vaccines facility in the Middle East.
The founder and Chairman of Vaccine Industrial Company
"The project, which has received a building permit from the Saudi Authority for Industrial Cities and Technology Zones (MODON), will be situated in Sudair City for Industry and Business, covering an impressive 42,000 square meters. Construction is set to begin in the first quarter of 2025."
Dr. Khaled Almosa
Head of Business Development at KeyPlants
"At KeyPlants, we are very proud to be part of this significant project, aiming to contribute to the Kingdom of Saudi Arabia's Vision 2030 and the goals outlined in the National Biotechnology strategy."
David Lindholm